The Relationship Between Decreased 5-hydroxyindole Metabolism and Mental Defect in Phenylketonuria

Overview

Journal Arch Dis Child

Specialty Pediatrics

Date 1959 Oct 1

PMID 14430380

Citations 6

Authors

C M PARE

M Sandler

R S STACEY

Affiliations

Soon will be listed here.

Citing Articles

Serotonin in experimental histidinemia.

Douay O, Kamoun P Neurochem Res. 1980; 5(8):897-903.

PMID: 7464987 DOI: 10.1007/BF00965789.

Specific 3H-imipramine binding in human platelets. Influence of age and sex.

Langer S, Briley M, Raisman R, Henry J, Morselli P Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(3):189-94.

PMID: 7432551 DOI: 10.1007/BF00505732.

Clinical neurochemistry of autism and associated disorders.

Young J, Kavanagh M, Anderson G, Shaywitz B, Cohen D J Autism Dev Disord. 1982; 12(2):147-65.

PMID: 6184361 DOI: 10.1007/BF01531305.

The pharmacokinetics of acetanilide and of diphenylhydantoin sodium.

Cunningham J, Bullen M, Evans D Eur J Clin Pharmacol. 1974; 7(6):461-6.

PMID: 4439870 DOI: 10.1007/BF00560359.

Behavioral, biochemical and maturation effects of early DL-para-chlorophenylalanine treatment.

Kilbey M, Harris R Psychopharmacologia. 1971; 19(4):334-46.

PMID: 4254728 DOI: 10.1007/BF00404378.

References

BLASCHKO H . Amine oxidase and amine metabolism. Pharmacol Rev. 1952; 4(4):415-58. View

Cawte J . Phenylketonuria. Med J Aust. 1954; 2(1):15-9. View

FELLMAN J . Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc Soc Exp Biol Med. 1956; 93(3):413-4. DOI: 10.3181/00379727-93-22773. View

PARE C, Sandler M, STACEY R . 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet. 1957; 272(6968):551-3. DOI: 10.1016/s0140-6736(57)90920-0. View

Armstrong M, McMillan A, SHAW K . 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim Biophys Acta. 1957; 25(2):422-3. DOI: 10.1016/0006-3002(57)90491-2. View

Davison A, Sandler M . Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites. Nature. 1958; 181(4603):186-7. DOI: 10.1038/181186b0. View

Born G, Ingram G, STACEY R . The relationship between 5-hydroxytryptamine and adenosine triphosphate in blood platelets. Br J Pharmacol Chemother. 1958; 13(1):62-4. PMC: 1481702. DOI: 10.1111/j.1476-5381.1958.tb00191.x. View

McISAAC W, PAGE I . New metabolites of serotonin in carcinoid urine. Science. 1958; 128(3323):537. DOI: 10.1126/science.128.3323.537. View

Davison A . Physiological role of monoamine oxidase. Physiol Rev. 1958; 38(4):729-47. DOI: 10.1152/physrev.1958.38.4.729. View

10.

WESTERMANN E, Balzer H, KNELL J . [Inhibition of serotonin formation by alpha-methyl-DOPA]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958; 234(3):194-205. View

11.

Elliott K . gamma-Aminobutyric acid and factor I. Rev Can Biol. 1958; 17(3):367-88. View

12.

Sandler M, Close H . Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor. Lancet. 1959; 2(7098):316-8. DOI: 10.1016/s0140-6736(59)91358-3. View

13.

Sandler M, Davies A, Rimington C . Effect of phenylacetic acid on the carcinoid syndrome. Lancet. 1959; 2(7098):318-22. DOI: 10.1016/s0140-6736(59)91359-5. View

14.

WEIL-MALHERBE H . The concentration of adrenaline in human plasma and its relation to mental activity. J Ment Sci. 1955; 101(425):733-55. DOI: 10.1192/bjp.101.425.733. View

15.

Hardisty R, STACEY R . 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955; 130(3):711-20. PMC: 1363408. DOI: 10.1113/jphysiol.1955.sp005437. View